Works by Griebeler, Marcio L.


Results: 13
    1
    2
    3

    De‐intensification of basal‐bolus therapy by replacing prandial insulin with once‐weekly subcutaneous semaglutide in individuals with well‐controlled type 2 diabetes: A single‐centre, open‐label randomised trial (TRANSITION‐T2D)

    Published in:
    Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 642, doi. 10.1111/dom.16057
    By:
    • Rodriguez, Paloma;
    • Breslaw, Nikki;
    • Xiao, Huijun;
    • Bena, Jim;
    • Jenkins, Kimberly;
    • Isaacs, Diana;
    • Zhou, Keren;
    • Griebeler, Marcio L.;
    • Burguera, Bartolome;
    • Pantalone, Kevin M.
    Publication type:
    Article
    4
    5

    An Obesity-Centric Approach with and Without Anti-Obesity Medications Compared to the Usual-Care Approach to Management of Patients with Obesity and Type 2 Diabetes in an Employer Setting: A Pragmatic Randomized Controlled Trial (EMPOWER-T2D).

    Published in:
    Diabetes Therapy, 2024, v. 15, n. 5, p. 1201, doi. 10.1007/s13300-024-01563-0
    By:
    • Pantalone, Kevin M.;
    • Rogen, Bruce;
    • Zirm, Patty;
    • Xiao, Huijun;
    • Bena, James;
    • Barnard, Gretchen;
    • Borukh, Elena;
    • Peechakara, Seenia;
    • Griebeler, Marcio L.;
    • Young, James B.;
    • Burguera, Bartolome
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13